International trade · 06/02/2023

U.S. International Trade Commission Investigates COVID-19 Diagnostics and Therapeutics Supply, Demand, and TRIPS Agreement Flexibilities

The U.S. International Trade Commission (USITC) launched an investigation into the supply, demand, and intellectual property aspects of COVID-19 diagnostics and therapeutics, following a request from the U.S. Trade Representative (USTR) under the Tariff Act of 1930, in response to the ongoing global pandemic.